Business Description
Magnasense AB
ISIN : SE0014401121
Share Class Description:
OSTO:MAGNA: Ordinary SharesCompare
Compare
Traded in other countries / regions
MAGNA.Sweden52Q.GermanyAEGBF.USA IPO Date
2020-06-26Description
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | -0.37 | |||||
| Debt-to-Equity | -2.11 | |||||
| Debt-to-EBITDA | -1.85 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -17.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -25.8 | |||||
| 3-Year EPS without NRI Growth Rate | -29.7 | |||||
| 3-Year FCF Growth Rate | -36.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.29 | |||||
| 9-Day RSI | 25.52 | |||||
| 14-Day RSI | 24.67 | |||||
| 6-1 Month Momentum % | -71.59 | |||||
| 12-1 Month Momentum % | -89.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.36 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.4 | |||||
| Shareholder Yield % | -301.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 3539100 | |||||
| Net Margin % | 3676800 | |||||
| FCF Margin % | 3653800 | |||||
| ROA % | -69.24 | |||||
| ROIC % | -64.66 | |||||
| ROC (Joel Greenblatt) % | -853.78 | |||||
| ROCE % | -51.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 30.07 | |||||
| EV-to-EBIT | -2.03 | |||||
| EV-to-EBITDA | -2.03 | |||||
| EV-to-Revenue | -42727 | |||||
| EV-to-FCF | -1.17 | |||||
| Earnings Yield (Greenblatt) % | -49.27 | |||||
| FCF Yield % | -651.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Magnasense AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | -0.001 | ||
| EPS (TTM) (kr) | -1.083 | ||
| Beta | 0 | ||
| Volatility % | 72.31 | ||
| 14-Day RSI | 24.67 | ||
| 14-Day ATR (kr) | 0.009299 | ||
| 20-Day SMA (kr) | 0.096395 | ||
| 12-1 Month Momentum % | -89.2 | ||
| 52-Week Range (kr) | 0.0851 - 1.25 | ||
| Shares Outstanding (Mil) | 62.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Magnasense AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Magnasense AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Magnasense AB Frequently Asked Questions
What is Magnasense AB(OSTO:MAGNA)'s stock price today?
The current price of OSTO:MAGNA is kr0.09. The 52 week high of OSTO:MAGNA is kr1.25 and 52 week low is kr0.09.
When is next earnings date of Magnasense AB(OSTO:MAGNA)?
The next earnings date of Magnasense AB(OSTO:MAGNA) is 2025-03-28.
Does Magnasense AB(OSTO:MAGNA) pay dividends? If so, how much?
Magnasense AB(OSTO:MAGNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers